the Jacob Heskel Gabbay Award in Biotechnology and Medicine to recognize, as early as possible in their careers, scientists in academia, medicine or industry whose work had outstanding scientific content and significant practical consequences in the biomedical sciences. The award was renamed the Jacob and Louise Gabbay Award in Biotechnology and Medicine in 2016 to honor Jacob’s wife, Louise Gabbay, who was instrumental in founding the award.
The 2022 Gabbay Award in Biotechnology and Medicine recognizes the combination of Steyaert’s fundamental research and his ability to apply the research to the development of therapeutic technologies. Steyaert bridged fundamental high-impact research in biomedical sciences with the mechanistic understanding of one of the biggest classes of pharmaceutical targets by combining structural biology and advanced biotechnology.
The award, given annually, consists of a medallion and a $25,000 cash prize or $30,000 to be shared between multiple winners. Recipients travel to Brandeis University in the fall of each year and present a lecture on their work, followed by a dinner at which the formal presentation takes place.
Awarded date
27 Oct 2022
Degree of recognition
International
Granting Organisations
Brandeis University, Gabbay Award in Biotechnology and Medicine